News and Blog

'Data - the new currency' seminars. NVIDIA is our first guest speaker

March 31, 2017 / no comments / in life science events

nvidia logo.jpg

Tuesday 25th April @15:00, Wellcome Genome Campus Hinxton, Cambridge

We are pleased to be welcoming NVIDIA - the pioneers of Artificial Intelligence as the first guest speakers as part of our 'Data - the new currency' seminar series. These seminars are being held in partnership with the Biodata Innovation Centre at the Wellcome Genome Campus at Hinxton, Cambridgeshire.

Andrea de Souza, Global Business Development Lead and David Hogan, Senior Director, Enterprise Business, EMEA will be co-presenting the following subject:
"The NVIDIA Toolbox for Biopharmaceutical Innovation"

The biopharmaceutical industry is deeply rooted in innovating with data and technologies to create breakthrough products that enable the healthcare community to diagnose, treat and prevent disease in a cost-effective way. As the healthcare community continues to innovate with big data, technology and advanced analytics methods, its partnership with NVIDIA continues to grow. Come learn how NVIDIA and the pharmaceutical industry can work together to master the art and science of innovating with artificial intelligence - for cancer, for heart disease and the microbiome.

The Eagle Genomics team will also be giving a short presentation:

"Smart Data in the Life Science Sector"

With data being the new currency of research, Abel Ureta-Vidal CEO and our Chief Data Scientist, Radouane Oudrhiri will demonstrate that to achieve real data driven innovation – both speed and economy of insight - data and data sets need to be treated and managed as data assets. To delay would result in loss of opportunity, which will compound over time to damage competitive advantage.

Agenda Summary

Date: Tuesday 25th April 15:00-16:00 with Refreshments afterwards

Location: Kendrew Lecture Theatre, Wellcome Genome Campus, Hinxton, Cambridgeshire

Welcome by Anthony Finbow, Executive Chairman, Eagle Genomics

Presentation 1 - "The NVIDIA Toolbox for Biopharmaceutical Innovation"

Presentation 2 - 'Smart Data in the Life Science Sector'

Drinks & Networking

 

If you would like to request to attend this seminar please complete the registration form.

REQUEST SEMINAR PLACE

Please note this event takes place at the Wellcome Genome Campus which has a security gate. Therefore all external attendees MUST be registered in advance of the event.

If you cannot attend but would like to attend future events, you can sign up to our newsletter:

SIGN UP TO SEMINAR NEWSLETTER

 

life science events

Anthony Finbow

About Anthony Finbow

As Executive Chairman and CEO, Anthony has built and exited a number of intellectual property rich B2B software companies. In particular, he was responsible for the turnaround, strategic repositioning and sale of private venture backed communications software company, Psytechnics to US Nasdaq listed NetScout. Similarly, as Managing Director of MetaSolv, he was responsible for doubling the size of the European business, prior to that company being acquired by Oracle. In addition to his extensive operational experience, Anthony has occupied every seat at the board table: Chairman, CEO, CFO, NXD and Investor Director (for both public and private companies) and is uniquely qualified in working with CEO’s and their management teams to meet the most significant challenges that they will encounter on their journey.